Acknowledgements The National Natural Science Foundation of China (NSFC) (grant number 82171575) and the Hubei Provincial Clinical Medical Research Center for Nephropathy (grant number OIR202402Z) were gratefully acknowledged
A new perspective
This study aimed to evaluate the effectiveness and safety of orforglipron, a nonpeptide, oral GLP-1 receptor agonist, for weight loss in adults with obesity
People with diabetes on insulin or oral hypoglycemic medications, due to additive blood sugar lowering effects
This shell protects the glutathione, allowing it to pass through the stomach and be absorbed more effectively at the cellular level
I know that we'll get into talking about a lot of the neurological benefits of being on these drugs, but let's talk about how they work, how they came about, and then for you may be giving us some of your least favorite false narratives that are surrounding these right now